These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33746085)

  • 1. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.
    Pose E; Torrents A; Reverter E; Perez-Campuzano V; Campos-Varela I; Avitabile E; Gratacós-Ginès J; Castellote J; Castells L; Colmenero J; Tort J; Ginès P; Crespo G
    J Hepatol; 2021 Aug; 75(2):275-283. PubMed ID: 33746085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    Pascasio JM; Vinaixa C; Ferrer MT; Colmenero J; Rubin A; Castells L; Manzano ML; Lorente S; Testillano M; Xiol X; Molina E; González-Diéguez L; Otón E; Pascual S; Santos B; Herrero JI; Salcedo M; Montero JL; Sánchez-Antolín G; Narváez I; Nogueras F; Giráldez Á; Prieto M; Forns X; Londoño MC
    J Hepatol; 2017 Dec; 67(6):1168-1176. PubMed ID: 28842296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting.
    Perricone G; Duvoux C; Berenguer M; Cortesi PA; Vinaixa C; Facchetti R; Mazzarelli C; Rockenschaub SR; Martini S; Morelli C; Monico S; Volpes R; Pageaux GP; Fagiuoli S; Belli LS;
    Liver Int; 2018 Dec; 38(12):2170-2177. PubMed ID: 29750389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
    Aravinthan AD; Barbas AS; Doyle AC; Tazari M; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Greig PD; Bhat M; Selzner N; Grant DR; Lilly LB; Renner EL
    Transpl Int; 2017 Nov; 30(11):1140-1149. PubMed ID: 28686307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.
    Belli LS; Berenguer M; Cortesi PA; Strazzabosco M; Rockenschaub SR; Martini S; Morelli C; Donato F; Volpes R; Pageaux GP; Coilly A; Fagiuoli S; Amaddeo G; Perricone G; Vinaixa C; Berlakovich G; Facchetti R; Polak W; Muiesan P; Duvoux C;
    J Hepatol; 2016 Sep; 65(3):524-31. PubMed ID: 27212241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
    Meunier L; Belkacemi M; Pageaux GP; Radenne S; Vallet-Pichard A; Houssel-Debry P; Duvoux C; Botta-Fridlund D; de Ledinghen V; Conti F; Anty R; Di Martino V; Debette-Gratien M; Leroy V; Gerster T; Lebray P; Alric L; Abergel A; Dumortier J; Besch C; Montialoux H; Samuel D; Duclos-Vallée JC; Coilly A
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience.
    Nabatchikova EA; Abdurakhmanov DT; Rozina TP; Nikulkina EN; Tanaschuk EL; Moiseev SV
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101714. PubMed ID: 33930587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
    Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
    Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    Lai JC; Dodge JL; Kappus MR; Dunn MA; Volk ML; Duarte-Rojo A; Ganger DR; Rahimi RS; McCulloch CE; Haugen CE; McAdams-DeMarco M; Ladner DP; Segev DL; Verna EC;
    J Hepatol; 2020 Sep; 73(3):575-581. PubMed ID: 32240717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting.
    Tonon M; Gagliardi R; Zeni N; Piano S
    Liver Transpl; 2024 Nov; 30(11):1181-1187. PubMed ID: 38926937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent.
    Bittermann T; Reddy KR
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2389-2397.e2. PubMed ID: 32971230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience.
    Martini S; Donato MF; Mazzarelli C; Rendina M; Visco-Comandini U; Filì D; Gianstefani A; Fagiuoli S; Melazzini M; Montilla S; Pani L; Petraglia S; Russo P; Trotta MP; Carrai P; Caraceni P;
    Liver Int; 2018 Apr; 38(4):733-741. PubMed ID: 28921807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-based disparities in delisting for being "too sick" for liver transplantation.
    Cullaro G; Sarkar M; Lai JC
    Am J Transplant; 2018 May; 18(5):1214-1219. PubMed ID: 29194969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
    Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
    J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT).
    Sáez-González E; Vinaixa C; San Juan F; Hontangas V; Benlloch S; Aguilera V; Rubín A; García M; Prieto M; López-Andujar R; Berenguer M
    Liver Int; 2018 Jun; 38(6):1022-1027. PubMed ID: 29105320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates.
    Payani E; Koliogiannis D; Schoenberg MB; Koch D; Eser-Valeri D; Denk G; Rehm M; Schäfer S; Ehmer U; Kremer AE; Meiser B; Werner J; Guba M; Börner N
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Flemming JA; Kim WR; Brosgart CL; Terrault NA
    Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation.
    Giard JM; Dodge JL; Terrault NA
    Liver Transpl; 2019 Sep; 25(9):1310-1320. PubMed ID: 31063642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.